Notch Therapeutics brings in $85m in Series A round

Vancouver-based biotechnology company Notch Therapeutics has raised $85 million in a Series A financing.

10 February 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Canada North America US Healthcare Briefs